References
- de Vries, E. G. E. and Pinedo, H. M.: Clinical implications of multidrug resistance to chemotherapy. p171-181. In: Ozols R. F. (ed), Molecular and Clinical Advances in Anticancer Drug Resistance. Kluwer Academic Publishers, Boston (1991)
- Endicott, J. A. and Ling, V.: The biochemistry of p-glycoprotein-mediated multidrug Resistance. Annu. Rev. Biochem. 58, 137-171 (1989) https://doi.org/10.1146/annurev.bi.58.070189.001033
- Ford, J. M. and Hait, W. N.: Pharmacology of drugs that alter multidrug resistance in cancer. Pharmacol. Rev. 42, 155-199 (1990)
- Gottesman, M. M. and Pastan, I.: Biochemistry of multidrug resistance mediated by the multidrug transporter. Ann. Rev. Biochem. 62, 385-427 (1993) https://doi.org/10.1146/annurev.bi.62.070193.002125
- Gottesman, M. M. and Pastan, I.: The multidrug transporter, a double-edged sword. J. Biol. Chem. 263, 12163-12166 (1988)
- Gros, P., Ben Neriah, Y., Croop, J. M. and Housman, D. E.: Isolation and expression of a complementary DNA that confers multidrug resistance. Nature. 323, 728-731 (1986) https://doi.org/10.1038/323728a0
- Young, R. C.: Drug resistance: The clinical problem. p. 1-11. In: Drug resistance in cancer chemotherapy. Kluwer Academic Publishers, Boston (1989)
- Ozols, R. F.: Molecular and clinical advances in anticancer drug resistance, Kluwer Academic Publisher, Boston (1991)
- Leyland-Jones, B., Dalton, W., Fisher G. A. and Sikik, B. I.: Reversal of multidrug resistance to cancer chemotherapy. Cancer 72 (11 Suppl), 3484-3488 (1993) https://doi.org/10.1002/1097-0142(19931201)72:11+<3484::AID-CNCR2820721615>3.0.CO;2-L
- Robert, J.: Multidrug resistance in oncology: diagnostic and therapeutic approaches. Eur. J. Clin. Invest. 29, 536-545 (1999) https://doi.org/10.1046/j.1365-2362.1999.00495.x
- Cole, S. P. and Deelay, R. G.: Multidrug resistance-associated protein: sequence correction. Science 260, 879 (1993)
- Cole, S. P. C., Bhardwaj, G., Gerlach, J. H., Mackie, J. E., Grant, C. E., Almquist, K. C., Stewart, A. J., Kurz, E. U., Duncan, A. M. V. and Deeley, R. G.: Overexpression of a transporter gene in a multidrug resistant human lung cancer cell line. Science 258, 1650-1654 (1992) https://doi.org/10.1126/science.1360704
- Grant, C. E., Valdimarsson, G., Hipfner, D. R., Almquist, K. C., Cole, S. P. and Deeley, R. G. Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs. Cancer Res. 54(2), 357-361 (1994)
- Bissett, D., Kerr, D. J., Cassidy, J., Meredith, P., Traugott, U. and Kaye, S. B.: Phase I and pharmacokinetic study of Dverapamil and doxorubicin. Br. J. Cancer 64(6), 1168-1171 (1991) https://doi.org/10.1038/bjc.1991.484
- Hyafil, F., Vergely, C., Du Vignaud, P. and Grand-Perret, T.: In vitro and in vivo reversal of multidrug resistance by GF120918, an acridonecarboxamide derivative. Cancer Res. 53, 4595-4602 (1993)
- McDevitt, C. A. and Callaghan, R.: How can we best use structural information on P-glycoprotein to design inhibitors? Pharmacol. Ther. 113(2), 429-441 (2007) https://doi.org/10.1016/j.pharmthera.2006.10.003
- Choi, S. U., Jung, N. P. and Kim, S. C.: Effect of ginseng saponin fractions and lipopolysaccharide on the tumoricidal activity of mouse macrophages. Korean J. Ginseng Sci. 14, 364-372 (1990)
- Hwang, W. I., Son, H. S., Ji, R. H. and Baik, N. G.: Effects of Panax ginseng and sodium ascorbate (vitamin C) treatment on cancer cell growth. I. Synergism of combined Panax ginseng and vitamin C action in vitro. Korean J. Ginseng Sci. 13: 242-247 (1989)
- Kikuchi, Y., Sasa, H., Kita, T., Hirata, J., Tode, T. and Nagata, I.: Inhibition of human ovarian cancer proliferation in vitro by ginsenoside Rh2 and adjuvant effects to cisplatin in vivo. Anti-Cancer Drugs, 2, 63-67 (1991) https://doi.org/10.1097/00001813-199102000-00009
- Kim, W. and Jung, N. P.: Effects of a ginseng saponin fraction on the tumoricidal activity of murine macrophage against K562 cells. Korean J. Ginseng Sci. 13, 24-29. (1989)
- Yun, Y. S., Moon, H. S., Oh, Y. R., Jo, S. K., Kim, Y. J. and Yun, T. K.: Effect of red ginseng on natural killer cell activity in mice with lung adenoma induced by urethane and benzo-(a) pyrene. Cancer Detect. Prev., Suppl. 1, 301-309 (1987)
- Park, J. D., Kim, D. S., Kwon, H. Y., Son, S. K., Lee, Y. H., Baek, N. I., Kim, S. I., and Rhee, D. K.: Effects of ginseng saponin on modulation of multidrug resistance. Arch. Pharm. Res. 19(3), 213-218 (1996) https://doi.org/10.1007/BF02976892
- Kim, S. W., Kwon, H. Y., Chi, D. W., Shim, J. H., Park, J. D., Lee, Y. H., Pyo, S. and Rhee, D. K.: Reversal of P-glycoprotein-mediated multidrug resistance by ginsenoside Rg(3). Biochem Pharmacol. 65, 75-82 (2003) https://doi.org/10.1016/S0006-2952(02)01446-6
- Skehan, P., Storeng, R., Scudiero, D., Monks, A., McMahon, J., Vistica, D., Warren, J. T., Bokesch, H., Kenney, S. and Boyd, M. R.: New colorimetric cytotoxicity assay for anticancer-drug screening. J. Natl. Cancer Inst. 82, 1107-1112 (1990) https://doi.org/10.1093/jnci/82.13.1107
Cited by
- Nutrigenomic approach to tackle the unpleasant journey to Helicobacter pylori-associated gastric carcinogenesis vol.12, pp.3, 2011, https://doi.org/10.1111/j.1751-2980.2011.00492.x